共 12 条
[1]
Kyle R.A., Plasma cell disorders, Cecil Textbook of Medicine, pp. 967-78, (1992)
[2]
Riedel D.A., Pottern L.M., The epidemiology of multiple myeloma, Hematol Oncol Clin North Am, 6, pp. 225-47, (1992)
[3]
Hiatt R.A., Friedman G.D., The frequency of kidney and urinary tract disease in a defined population, Kidney Int, 22, pp. 63-8, (1981)
[4]
Krieger N., Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology, Am J Public Health, 82, pp. 703-10, (1992)
[5]
Selby J.V., Friedman G.D., Fireman B.H., Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up, Cancer Res, 49, pp. 5736-47, (1989)
[6]
Collen M.F., Davis L.F., The multitest laboratory in health care, J Occup Med, 11, pp. 355-60, (1969)
[7]
Breslow N.E., Day N.E., Statistical Methods in Cancer Research. Vol. 2. The Design and Analysis of Cohort Studies, (1987)
[8]
Harrell F.E., The PHLGM procedure, SUGI Supplemental Library User's Guide, pp. 437-66, (1986)
[9]
Boffeta P., Stellman S.D., Garfinkel L., A case-control study of multiple myeloma nested in the American Cancer Society prospective study, International Journal of Cancer, 43, pp. 554-9, (1989)
[10]
Chandra R.K., Nutrition and the immune system, Proc Nutr Soc, 52, pp. 77-84, (1993)